Category: Diseases & Conditions
Japan Diseases & Conditions
-
Japan Diabetes Drugs and Devices Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)
... is expected to reach USD 6.40 billion by 2029, growing at a CAGR of greater than 3.20% during the forecast period (2024-2029). Japan is experiencing a significant rise in its diabetes population, with the country ... Read More
-
Mono Vaccine Market Size, Trends, Analysis, and Outlook By Type (Meningococcal Vaccine, Japanese Encephalitis Vaccine, Hepatitis Vaccine, Yellow Fever Vaccine, Others), by Region, Country, Segment, and Companies, 2024-2030
... poised to register 5.59% growth (CAGR) from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Mono Vaccine market By Type (Meningococcal Vaccine, Japanese Encephalitis ... Read More
-
Asia-Pacific Omega-3 Supplements Market, By Source (Fish Oil, Krill Oil, Algae Oil, Others), By Form (Tablets, Capsules, Soft Gels, Others), By Functionality (Cardiovascular Health, Brain, Nervous System & Mental Health, Eye Diseases, Diabetes, Others), By End User (Adults, Geriatric, Pregnant Women, Children, Infants), By Distribution Channel (Supermarkets/ Hypermarkets/Food Stores, Drug Stores & Pharmacies, Online Retailers, Others), By Country (China, India, Japan, South Korea, Australia & New Zealand, Indonesia, Malaysia, Singapore, Vietnam, Rest of APAC), Trend Analysis, Competitive Landscape & Forecast, 2019–2030
... End User (Adults, Geriatric, Pregnant Women, Children, Infants), By Distribution Channel (Supermarkets/ Hypermarkets/Food Stores, Drug Stores & Pharmacies, Online Retailers, Others), By Country (China, India, Japan, South Korea, Australia & New Zealand, Indonesia, Malaysia, Singapore, ... Read More
-
Japan Diabetes Devices and Drugs Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2030
... the Japan market. Moreover, the report provides deep insights into demand forecasts, market trends, and, micro and macro indicators in the Japan market. Also, factors that are driving and restraining the diabetes devices and drugs ... Read More
-
Japan Insulin Drugs and Delivery Devices - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029
... 2024, and is expected to reach USD 9.57 billion by 2029, growing at a CAGR of 2.40% during the forecast period (2024-2029). The number of Japanese victims during the COVID-19 pandemic was lower than in ... Read More
-
Travel Vaccines Market Report by Composition (Mono Vaccines, Combination Vaccines), Disease (Hepatitis A, DPT, Yellow Fever, Typhoid, Hepatitis B, Measles and Mumps, Rabies, Meningococcal, Varicella, Japanese Encephalitis, and Others), and Region 2024-2032
... vaccines market size reached US$ 4.0 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 9.4 Billion by 2032, exhibiting a growth rate (CAGR) of 9.6% during 2024-2032. The market is ... Read More
-
Asia Pacific Next Generation Antibody Market, By Therapeutic Area (Oncology, Autoimmune/Inflammatory); By Technology (Antibody-Drug Conjugates (ADC's), Bispecific Antibodies, FC Engineered Antibodies, Antibody Fragments and Antibody-like Proteins, Biosimilar Antibody Products); By Country (China, India, Japan, South Korea, Indonesia, Vietnam, Malaysia, Rest of Asia Pacific), Trend Analysis, Competitive Landscape & Forecast, 2019–2030
... antibody research and development programs, advancements in biotechnology, and expanding healthcare infrastructure. BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, estimated the Asia Pacific Next Generation Antibody Market size ... Read More
-
2024 Global Clinical Chemistry and Immunodiagnostics Market in the US, Europe, Japan - 2023 Supplier Shares and Strategies by Country, 2023-2028 Volume and Sales Segment Forecasts for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein and TDM Te
... TDM Tests This unique report from LeadingMarketResearch.com provides information and analysis not available from any other published source . Clinical Chemistry Albumin, Alkaline Phosphatase, ALT/SGPT, Ammonia, Amylase, Apolipoprotein A-1, Apolipoprotein B, AST/SGOT, Beta-Hydroxybutyrate, Bilirubin (Direct), ... Read More
-
Japan Artemisinin Combination Therapy Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2030
... market. Moreover, the report provides deep insights into demand forecasts, market trends, and, micro and macro indicators in the Japan market. Also, factors that are driving and restraining the artemisinin combination therapy market are highlighted ... Read More
-
Japan In Vitro Diagnostics Market Assessment By Product Type [Instruments, Reagents and Consumables, Data Management Software], By Techniques [Immunodiagnostics, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation and Haemostasias, Urinalysis, Others], By Settings [Laboratories, Point-of-Care], By Application [Infectious Diseases, Diabetes, Drug Testing/Pharmacogenomics, Autoimmune Diseases, Cardiology, Oncology, HIV/AIDS, Nephrology, Gastroenterology, Others], By End-user [Clinical Laboratories, Hospitals, Point-of-care testing centers, Others], By Region, Opportunities and Forecast, FY2017-FY2031F
... Application [Infectious Diseases, Diabetes, Drug Testing/Pharmacogenomics, Autoimmune Diseases, Cardiology, Oncology, HIV/AIDS, Nephrology, Gastroenterology, Others], By End-user [Clinical Laboratories, Hospitals, Point-of-care testing centers, Others], By Region, Opportunities and Forecast, FY2017-FY2031F Japan In Vitro Diagnostics Market size ... Read More
-
Asia Pacific Multiple Sclerosis Drugs Market, By Disease Type (Relapsing-Remitting Multiple Sclerosis (RRMS), Secondary Progressive Multiple Sclerosis (SPMS), Primary Progressive Multiple Sclerosis (PPMS), Severe Relapsing-Remitting Multiple Sclerosis (RES)); By Treatment (Preventive Therapies, Abortive Therapies/Treatment of Acute Exacerbations, Symptomatic Therapies); By Drug Type (Branded, Generic); By End User (Hospital & Clinics, Diagnostic Laboratories); By Country (China, India, Japan, South Korea, Australia & New Zealand, Indonesia, Malaysia, Singapore, Vietnam, Rest of APAC), Competitive Landscape & Forecast, 2019–2029
... End User (Pharmaceutical & Biopharmaceutical Companies, Labs & Research Institutes, Healthcare Providers, Healthcare Payers); By Application (Drug Discovery & Development, Medical Diagnostics, Genomics & Precision Medicine, Radiotherapy, Risk Analysis); By Region (North America, Europe, Asia ... Read More
-
Japan Cancer Therapeutics Market Assessment, By Applications [Lung Cancer, Blood Cancer, Colorectal Cancer, Prostate Cancer, Breast Cancer, Cervical Cancer, Glioblastoma, Head & Neck Cancer, Malignant Meningioma, Mesothelioma, Melanoma, Others], By Therapeutics [Chemotherapy, Targeted Therapy, Immunotherapy, Hormonal Therapy, Other], By Top Selling Drugs [Revlimid, Avastin, Herceptin, Rituxan, Opdivo, Gleevec, Velcade, Imbruvica, Ibrance, Zytiga, Alimta, Xtandi, Tarceva, Perjeta, Temodar, Others], By End-user [Hospitals, Specialty Clinics, Cancer & Radiation Therapy Centers], By Region, By Opportunities and Forecast, FY2017-FY2031F
... Hormonal Therapy, Other], By Top Selling Drugs [Revlimid, Avastin, Herceptin, Rituxan, Opdivo, Gleevec, Velcade, Imbruvica, Ibrance, Zytiga, Alimta, Xtandi, Tarceva, Perjeta, Temodar, Others], By End-user [Hospitals, Specialty Clinics, Cancer & Radiation Therapy Centers], By Region, ... Read More
-
Japanese Encephalitis Vaccine Market Report: Trends, Forecast and Competitive Analysis to 2030
... and online markets. The global japanese encephalitis vaccine market is expected to reach an estimated $0.3 billion by 2030 with a CAGR of 5.8% from 2024 to 2030. The major drivers for this market are ... Read More
-
Dairy Products and Alternatives in Japan
... in production costs. Most of the categories within dairy products and alternatives, except for cheese, which heavily relies on imports, had not experienced high unit price increases until 2022, as there had been no supply ... Read More
-
Japan Telemental Health Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2030
... indicators in the Japan market. Also, factors that are driving and restraining the telemental health market are highlighted in the study. This is an in-depth business intelligence report based on qualitative and quantitative parameters of ... Read More
-
Japan Blood Pressure Monitoring Market Overview, 2028
... system, enhanced medical technology, and an aging population, there is a greater need for accurate and accessible blood pressure monitoring solutions. Blood pressure control is critical to addressing cardiovascular illnesses, which continue to be a ... Read More
-
Japan Prostate Cancer Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2030
... the report provides deep insights intdemand forecasts, market trends, and, micrand macrindicators in the Japan market. Also, factors that are driving and restraining the prostate cancer market are highlighted in the study. This is an ... Read More
-
Japan Diabetes Care Devices Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
... to reach USD 9.56 billion by 2028, growing at a CAGR of 3.07% during the forecast period (2023-2028). The COVID-19 pandemic has had a substantial impact on the diabetes care devices market. The prevalence of ... Read More
-
Japan Oral Anti-Diabetic Drug Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
... USD 2.89 billion by 2028, at a CAGR of 4.60% during the forecast period (2023-2028). Japanese victims of the COVID-19 pandemic were less numerous than those from other nations, which may be related to genetic ... Read More
-
Japan Diabetes Drugs Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
... USD 4.00 billion by 2028, growing at a CAGR of 3.60% during the forecast period (2023-2028). The COVID-19 pandemic has had a substantial impact on the diabetes drugs market. The prevalence of diabetes in people ... Read More
-
Japan Influenza Vaccine Market Assessment, By Type of Vaccine [Inactivated Influenza Vaccine, Live Attenuated Influenza Vaccine], By Type of Influenza [Seasonal and Pandemic], By Formulation [Trivalent, Quadrivalent], By Technology [Egg-based, Cell culture and Recombinant], By Age group [Paediatric and Adult], By Route of Administration [Intra-muscular injection, Nasal Spray], By Distribution Channel [Hospital, Retail Pharmacies, Government Suppliers and Others], By Region, By Opportunities and Forecast, FY2017-FY2031
... Age group [Paediatric and Adult], By Route of Administration [Intra-muscular injection, Nasal Spray], By Distribution Channel [Hospital, Retail Pharmacies, Government Suppliers and Others], By Region, By Opportunities and Forecast, FY2017-FY2031 Japan Influenza Vaccine Market size ... Read More
-
Japan General Surgery Device Procedures Count by Segments (Airway Stent Procedures, Bariatric Surgery Procedures, Biopsy Procedures, Cholecystectomy Procedures, Colectomy Procedures and Others) and Forecast to 2030
... 2030” is a comprehensive databook report, covering key procedures data on the Japan General Surgery Device Procedures. The databook report provides procedure volumes within segments - Airway Stent Procedures, Bariatric Surgery Procedures, Biopsy Procedures, Cholecystectomy ... Read More
-
Japan Embolization Particle Procedures Count by Segments (Embolization Particle Procedures to treat Hepatocellular Carcinoma, Embolization Particle Procedures to treat Intrahepatic Cholangiocarcinoma, Embolization Particle Procedures to treat Uterine Fibroids and Others) and Forecast to 2030
... GlobalData’s “Japan Embolization Particle Procedures Outlook to 2030” is a comprehensive databook report, covering key procedures data on the Japan Embolization Particle Procedures. The databook report provides procedure volumes within segments - Embolization Particle Procedures ... Read More
-
Japan Platinum Based Cancer Drug Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2030
... the Japan market. Moreover, the report provides deep insights into demand forecasts, market trends, and, micro and macro indicators in the Japan market. Also, factors that are driving and restraining the platinum based cancer drug ... Read More
-
Japan Commercial Construction Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023 - 2028)
... CAGR of more than 6.7%.Even though some parts of the building industry are having trouble right now, Japan's medium- to long-term growth story is still strong.Over the upcoming four quarters, the Japanese building sector is ... Read More
Research Assistance
